• Je něco špatně v tomto záznamu ?

Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects

X. Guo, W. Lin, W. Wen, J. Huyghe, S. Bien, Q. Cai, T. Harrison, Z. Chen, C. Qu, J. Bao, J. Long, Y. Yuan, F. Wang, M. Bai, GR. Abecasis, D. Albanes, SI. Berndt, S. Bézieau, DT. Bishop, H. Brenner, S. Buch, A. Burnett-Hartman, PT. Campbell, S....

. 2021 ; 160 (4) : 1164-1178.e6. [pub] 20201012

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026014

Grantová podpora
R01 CA067941 NCI NIH HHS - United States
U01 HG004446 NHGRI NIH HHS - United States
K05 CA154337 NCI NIH HHS - United States
HHSN268201100003I NHLBI NIH HHS - United States
U01 CA067941 NCI NIH HHS - United States
R01 CA059045 NCI NIH HHS - United States
HHSN268201100001I NHLBI NIH HHS - United States
R01 CA197350 NCI NIH HHS - United States
R01 CA076366 NCI NIH HHS - United States
R01 CA188214 NCI NIH HHS - United States
R35 CA197735 NCI NIH HHS - United States
C8221/A19170 Cancer Research UK - United Kingdom
R01 CA204279 NCI NIH HHS - United States
U01 HG004438 NHGRI NIH HHS - United States
R37 CA227130 NCI NIH HHS - United States
U01 CA074799 NCI NIH HHS - United States
U10 CA037429 NCI NIH HHS - United States
U01 CA182883 NCI NIH HHS - United States
R01 CA072520 NCI NIH HHS - United States
P01 CA087969 NCI NIH HHS - United States
14136 Cancer Research UK - United Kingdom
HHSN261201000035C NCI NIH HHS - United States
P30 CA015704 NCI NIH HHS - United States
HHSN268201100004I NHLBI NIH HHS - United States
P30 CA006973 NCI NIH HHS - United States
U24 CA074783 NCI NIH HHS - United States
P01 CA055075 NCI NIH HHS - United States
N01 CN067009 NCI NIH HHS - United States
R01 CA160356 NCI NIH HHS - United States
UG1 CA189974 NCI NIH HHS - United States
R01 CA151993 NCI NIH HHS - United States
P30 DK058404 NIDDK NIH HHS - United States
HHSN268201100046C NHLBI NIH HHS - United States
P30 DK034987 NIDDK NIH HHS - United States
Department of Health - United Kingdom
P50 CA150964 NCI NIH HHS - United States
R01 CA048998 NCI NIH HHS - United States
U01 CA137088 NCI NIH HHS - United States
R01 CA189184 NCI NIH HHS - United States
U01 CA167552 NCI NIH HHS - United States
HHSN268201100003C WHI NIH HHS - United States
Z01 CP010200 Intramural NIH HHS - United States
U24 CA074794 NCI NIH HHS - United States
U01 CA164930 NCI NIH HHS - United States
N01PC35137 NCI NIH HHS - United States
R01 CA066635 NCI NIH HHS - United States
U24 CA074806 NCI NIH HHS - United States
U01 CA206110 NCI NIH HHS - United States
1000143 Medical Research Council - United Kingdom
C490/A16561 Cancer Research UK - United Kingdom
R21 CA191312 NCI NIH HHS - United States
HHSN268201200008C NHLBI NIH HHS - United States
R01 CA137178 NCI NIH HHS - United States
U24 CA097735 NCI NIH HHS - United States
U01 CA074794 NCI NIH HHS - United States
P30 CA008748 NCI NIH HHS - United States
U01 CA167551 NCI NIH HHS - United States
HHSN261201300011C CCR NIH HHS - United States
HHSN261201300012I NCI NIH HHS - United States
P30 CA014089 NCI NIH HHS - United States
C570/A16491 Cancer Research UK - United Kingdom
R01 CA081488 NCI NIH HHS - United States
R01 CA143237 NCI NIH HHS - United States
N01PC35142 NCI NIH HHS - United States
HHSN271201100004C NIA NIH HHS - United States
R01 CA201407 NCI NIH HHS - United States
R01 CA063464 NCI NIH HHS - United States
P01 CA033619 NCI NIH HHS - United States
UM1 CA186107 NCI NIH HHS - United States
MR/M012190/1 Medical Research Council - United Kingdom
HHSN268201100002C WHI NIH HHS - United States
R01 CA207371 NCI NIH HHS - United States
HHSN261201300021C NCI NIH HHS - United States
R03 CA153323 NCI NIH HHS - United States
HHSN261201000035I NCI NIH HHS - United States
R01 CA144040 NCI NIH HHS - United States
R01 CA042182 NCI NIH HHS - United States
C588/A19167 Cancer Research UK - United Kingdom
R01 CA060987 NCI NIH HHS - United States
U01 CA097735 NCI NIH HHS - United States
T32 ES013678 NIEHS NIH HHS - United States
R01 CA136726 NCI NIH HHS - United States
P30 CA016058 NCI NIH HHS - United States
UM1 CA167552 NCI NIH HHS - United States
K05 CA152715 NCI NIH HHS - United States
P20 CA252728 NCI NIH HHS - United States
UM1 CA167551 NCI NIH HHS - United States
U01 CA122839 NCI NIH HHS - United States
HHSN261201500005C NCI NIH HHS - United States
HHSN268201100002I NHLBI NIH HHS - United States
U01 CA074783 NCI NIH HHS - United States
U01 CA084968 NCI NIH HHS - United States
KL2 TR000421 NCATS NIH HHS - United States
U24 CA074799 NCI NIH HHS - United States
P01 CA196569 NCI NIH HHS - United States
U01 CA074806 NCI NIH HHS - United States
U24 CA074800 NCI NIH HHS - United States
P50 CA127003 NCI NIH HHS - United States
UM1 CA182883 NCI NIH HHS - United States
K07 CA190673 NCI NIH HHS - United States
HHSN268201200008I NHLBI NIH HHS - United States
HHSN261201000121C NCI NIH HHS - United States
R01 CA193677 NCI NIH HHS - United States
U01 CA164973 NCI NIH HHS - United States
R37 CA054281 NCI NIH HHS - United States
U01 CA074800 NCI NIH HHS - United States
HHSN268201100001C WHI NIH HHS - United States
HHSN268201100004C WHI NIH HHS - United States
R01 CA097325 NCI NIH HHS - United States
U19 CA148107 NCI NIH HHS - United States
N01 CN043302 NCI NIH HHS - United States
NV17-30920A MZ0 CEP - Centrální evidence projektů

BACKGROUND AND AIMS: Susceptibility genes and the underlying mechanisms for the majority of risk loci identified by genome-wide association studies (GWAS) for colorectal cancer (CRC) risk remain largely unknown. We conducted a transcriptome-wide association study (TWAS) to identify putative susceptibility genes. METHODS: Gene-expression prediction models were built using transcriptome and genetic data from the 284 normal transverse colon tissues of European descendants from the Genotype-Tissue Expression (GTEx), and model performance was evaluated using data from The Cancer Genome Atlas (n = 355). We applied the gene-expression prediction models and GWAS data to evaluate associations of genetically predicted gene-expression with CRC risk in 58,131 CRC cases and 67,347 controls of European ancestry. Dual-luciferase reporter assays and knockdown experiments in CRC cells and tumor xenografts were conducted. RESULTS: We identified 25 genes associated with CRC risk at a Bonferroni-corrected threshold of P < 9.1 × 10-6, including genes in 4 novel loci, PYGL (14q22.1), RPL28 (19q13.42), CAPN12 (19q13.2), MYH7B (20q11.22), and MAP1L3CA (20q11.22). In 9 known GWAS-identified loci, we uncovered 9 genes that have not been reported previously, whereas 4 genes remained statistically significant after adjusting for the lead risk variant of the locus. Through colocalization analysis in GWAS loci, we additionally identified 12 putative susceptibility genes that were supported by TWAS analysis at P < .01. We showed that risk allele of the lead risk variant rs1741640 affected the promoter activity of CABLES2. Knockdown experiments confirmed that CABLES2 plays a vital role in colorectal carcinogenesis. CONCLUSIONS: Our study reveals new putative susceptibility genes and provides new insight into the biological mechanisms underlying CRC development.

Behavioral and Epidemiology Research Group American Cancer Society Atlanta Georgia

Cancer Epidemiology Division Cancer Council Victoria Melbourne Victoria Australia

Cancer Science Institute of Singapore National University of Singapore Singapore

Center for Gastrointestinal Biology and Disease University of North Carolina Chapel Hill North Carolina

Center for Public Health Genomics University of Virginia Charlottesville Virginia

Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health The University of Melbourne Melbourne Victoria Australia

Channing Division of Network Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts

CIBER Epidemiología y Salud Pública Madrid Spain

Clinical Genetics Service Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

Department of Biostatistics and Center for Statistical Genetics University of Michigan Ann Arbor Michigan

Department of Cancer Biology and Genetics and the Comprehensive Cancer Center The Ohio State University Columbus Ohio

Department of Cancer Epidemiology H Lee Moffitt Cancer Center and Research Institute Tampa Florida

Department of Clinical Genetics Karolinska University Hospital Stockholm Sweden

Department of Community Medicine and Epidemiology Lady Davis Carmel Medical Center Haifa Israel

Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland

Department of Epidemiology University of Washington School of Public Health Seattle Washington

Department of Family Medicine University of Virginia Charlottesville Virginia

Department of General Surgery University Hospital Rostock Rostock Germany

Department of Genome Sciences University of Washington Seattle Washington

Department of Hematology Oncology Chonnam National University Hospital Hwasun South Korea

Department of Internal Medicine University of Utah Salt Lake City Utah

Department of Medicine 1 University Hospital Dresden Technische Universität Dresden Dresden Germany

Department of Medicine and Epidemiology University of Pittsburgh Medical Center Pittsburgh Pennsylvania

Department of Medicine Weill Cornell Medical College New York New York

Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czech Republic

Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

Department of Population and Quantitative Health Sciences Case Western Reserve University Cleveland Ohio

Department of Preventive Medicine and University of Southern California Norris Comprehensive Cancer Center Keck School of Medicine University of Southern California Los Angeles California

Department of Public Health and Primary Care University of Cambridge Cambridge United Kingdom

Department of Radiation Sciences Oncology Unit Umeå University Umeå Sweden

Department of Surgery Chonnam National University Hwasun Hospital and Medical School Hwasun Korea

Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda Maryland

Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany

Division of Clinical Epidemiology and Aging Research German Cancer Research Center Heidelberg Germany

Division of Epidemiology Department of Medicine Vanderbilt Epidemiology Center and Vanderbilt Ingram Cancer Center Vanderbilt University School of Medicine Nashville Tennessee

Division of Epidemiology Department of Population Health New York University School of Medicine New York New York

Division of Gastroenterology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts

Division of Human Genetics Department of Internal Medicine The Ohio State University Comprehensive Cancer Center Columbus Ohio

Division of Human Nutrition and Health Wageningen University and Research Wageningen the Netherlands

Division of Preventive Oncology German Cancer Research Center and National Center for Tumor Diseases Heidelberg Germany

Division of Public Health Sciences Fred Hutchinson Cancer Research Center Seattle Washington

Division of Research Kaiser Permanente Northern California Oakland California

Gastroenterology Department Hospital Clínic Institut d'Investigacions Biomèdiques August Pi i Sunyer Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas University of Barcelona Barcelona Spain

Health Sciences Research Mayo Clinic Scottsdale Arizona

Huntsman Cancer Institute and Department of Population Health Sciences University of Utah Salt Lake City Utah

Institute for Health Research Kaiser Permanente Colorado Denver Colorado

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Cancer Research Department of Medicine 1 Medical University Vienna Vienna Austria

Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Leeds Institute of Cancer and Pathology University of Leeds Leeds United Kingdom

Lunenfeld Tanenbaum Research Institute Mount Sinai Hospital University of Toronto Toronto Ontario Canada

Memorial University of Newfoundland Discipline of Genetics St John's Newfoundland and Labrador Canada

National University Cancer Institute Singapore

Nutrition and Metabolism Section International Agency for Research on Cancer World Health Organization Lyon France

Oncology Data Analytics Program Catalan Institute of Oncology IDIBELL L'Hospitalet de Llobregat Barcelona Spain

Ruth and Bruce Rappaport Faculty of Medicine Technion Israel Institute of Technology Haifa Israel

School of Public Health University of Washington Seattle Washington

Service de Génétique Médicale Centre Hospitalier Universitaire Nantes France

SWOG Statistical Center Fred Hutchinson Cancer Research Center Seattle Washington

The Kidney Disease Center the 1st Affiliated Hospital Institute of Translational Medicine Zhejiang University School of Medicine Hangzhou China

University Medical Centre Hamburg Eppendorf University Cancer Centre Hamburg Hamburg Germany

University of Hawaii Cancer Center Honolulu Hawaii

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026014
003      
CZ-PrNML
005      
20211026133257.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1053/j.gastro.2020.08.062 $2 doi
035    __
$a (PubMed)33058866
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Guo, Xingyi $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. Electronic address: xingyi.guo@vumc.org
245    10
$a Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects / $c X. Guo, W. Lin, W. Wen, J. Huyghe, S. Bien, Q. Cai, T. Harrison, Z. Chen, C. Qu, J. Bao, J. Long, Y. Yuan, F. Wang, M. Bai, GR. Abecasis, D. Albanes, SI. Berndt, S. Bézieau, DT. Bishop, H. Brenner, S. Buch, A. Burnett-Hartman, PT. Campbell, S. Castellví-Bel, AT. Chan, J. Chang-Claude, SJ. Chanock, SH. Cho, DV. Conti, A. Chapelle, EJM. Feskens, SJ. Gallinger, GG. Giles, PJ. Goodman, A. Gsur, M. Guinter, MJ. Gunter, J. Hampe, H. Hampel, RB. Hayes, M. Hoffmeister, E. Kampman, HM. Kang, TO. Keku, HR. Kim, L. Le Marchand, SC. Lee, CI. Li, L. Li, A. Lindblom, N. Lindor, RL. Milne, V. Moreno, N. Murphy, PA. Newcomb, DA. Nickerson, K. Offit, R. Pearlman, PDP. Pharoah, EA. Platz, JD. Potter, G. Rennert, LC. Sakoda, C. Schafmayer, SL. Schmit, RE. Schoen, FR. Schumacher, ML. Slattery, YR. Su, CM. Tangen, CM. Ulrich, FJB. van Duijnhoven, B. Van Guelpen, K. Visvanathan, P. Vodicka, L. Vodickova, V. Vymetalkova, X. Wang, E. White, A. Wolk, MO. Woods, G. Casey, L. Hsu, MA. Jenkins, SB. Gruber, U. Peters, W. Zheng
520    9_
$a BACKGROUND AND AIMS: Susceptibility genes and the underlying mechanisms for the majority of risk loci identified by genome-wide association studies (GWAS) for colorectal cancer (CRC) risk remain largely unknown. We conducted a transcriptome-wide association study (TWAS) to identify putative susceptibility genes. METHODS: Gene-expression prediction models were built using transcriptome and genetic data from the 284 normal transverse colon tissues of European descendants from the Genotype-Tissue Expression (GTEx), and model performance was evaluated using data from The Cancer Genome Atlas (n = 355). We applied the gene-expression prediction models and GWAS data to evaluate associations of genetically predicted gene-expression with CRC risk in 58,131 CRC cases and 67,347 controls of European ancestry. Dual-luciferase reporter assays and knockdown experiments in CRC cells and tumor xenografts were conducted. RESULTS: We identified 25 genes associated with CRC risk at a Bonferroni-corrected threshold of P < 9.1 × 10-6, including genes in 4 novel loci, PYGL (14q22.1), RPL28 (19q13.42), CAPN12 (19q13.2), MYH7B (20q11.22), and MAP1L3CA (20q11.22). In 9 known GWAS-identified loci, we uncovered 9 genes that have not been reported previously, whereas 4 genes remained statistically significant after adjusting for the lead risk variant of the locus. Through colocalization analysis in GWAS loci, we additionally identified 12 putative susceptibility genes that were supported by TWAS analysis at P < .01. We showed that risk allele of the lead risk variant rs1741640 affected the promoter activity of CABLES2. Knockdown experiments confirmed that CABLES2 plays a vital role in colorectal carcinogenesis. CONCLUSIONS: Our study reveals new putative susceptibility genes and provides new insight into the biological mechanisms underlying CRC development.
650    _2
$a alely $7 D000483
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a karcinogeneze $x genetika $7 D063646
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a kohortové studie $7 D015331
650    _2
$a kolorektální nádory $x epidemiologie $x genetika $7 D015179
650    _2
$a genový knockdown $7 D055785
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a lidé $7 D006801
650    12
$a modely genetické $7 D008957
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a promotorové oblasti (genetika) $x genetika $7 D011401
650    _2
$a sekvenování transkriptomu $7 D000081246
650    _2
$a rizikové faktory $7 D012307
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lin, Weiqiang $u The Kidney Disease Center, the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Wen, Wanqing $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee
700    1_
$a Huyghe, Jeroen $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Bien, Stephanie $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Cai, Qiuyin $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee
700    1_
$a Harrison, Tabitha $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Chen, Zhishan $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee
700    1_
$a Qu, Conghui $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Bao, Jiandong $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee
700    1_
$a Long, Jirong $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee
700    1_
$a Yuan, Yuan $u The Kidney Disease Center, the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Wang, Fangqin $u The Kidney Disease Center, the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Bai, Mengqiu $u The Kidney Disease Center, the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Abecasis, Goncalo R $u Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan
700    1_
$a Albanes, Demetrius $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
700    1_
$a Berndt, Sonja I $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
700    1_
$a Bézieau, Stéphane $u Service de Génétique Médicale, Centre Hospitalier Universitaire, Nantes, France
700    1_
$a Bishop, D Timothy $u Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom
700    1_
$a Brenner, Hermann $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany
700    1_
$a Buch, Stephan $u Department of Medicine I, University Hospital Dresden, Technische Universität Dresden, Dresden, Germany
700    1_
$a Burnett-Hartman, Andrea $u Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado
700    1_
$a Campbell, Peter T $u Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia
700    1_
$a Castellví-Bel, Sergi $u Gastroenterology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University of Barcelona, Barcelona, Spain
700    1_
$a Chan, Andrew T $u Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
700    1_
$a Chang-Claude, Jenny $u Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg, Hamburg, Germany
700    1_
$a Chanock, Stephen J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
700    1_
$a Cho, Sang Hee $u Department of Hematology-Oncology, Chonnam National University Hospital, Hwasun, South Korea
700    1_
$a Conti, David V $u Department of Preventive Medicine and University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California
700    1_
$a Chapelle, Albert de la $u Department of Cancer Biology and Genetics and the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
700    1_
$a Feskens, Edith J M $u Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, the Netherlands
700    1_
$a Gallinger, Steven J $u Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
700    1_
$a Giles, Graham G $u Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
700    1_
$a Goodman, Phyllis J $u SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Gsur, Andrea $u Institute of Cancer Research, Department of Medicine I, Medical University Vienna, Vienna, Austria
700    1_
$a Guinter, Mark $u Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia
700    1_
$a Gunter, Marc J $u Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France
700    1_
$a Hampe, Jochen $u Department of Medicine I, University Hospital Dresden, Technische Universität Dresden, Dresden, Germany
700    1_
$a Hampel, Heather $u Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
700    1_
$a Hayes, Richard B $u Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, New York
700    1_
$a Hoffmeister, Michael $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
700    1_
$a Kampman, Ellen $u Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, the Netherlands
700    1_
$a Kang, Hyun Min $u Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan
700    1_
$a Keku, Temitope O $u Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina
700    1_
$a Kim, Hyeong Rok $u Department of Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun, Korea
700    1_
$a Le Marchand, Loic $u University of Hawaii Cancer Center, Honolulu, Hawaii
700    1_
$a Lee, Soo Chin $u National University Cancer Institute, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore
700    1_
$a Li, Christopher I $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Li, Li $u Department of Family Medicine, University of Virginia, Charlottesville, Virginia
700    1_
$a Lindblom, Annika $u Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Lindor, Noralane $u Health Sciences Research, Mayo Clinic, Scottsdale, Arizona
700    1_
$a Milne, Roger L $u Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
700    1_
$a Moreno, Victor $u Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain
700    1_
$a Murphy, Neil $u Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia
700    1_
$a Newcomb, Polly A $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; School of Public Health, University of Washington, Seattle, Washington
700    1_
$a Nickerson, Deborah A $u Department of Genome Sciences, University of Washington, Seattle, Washington
700    1_
$a Offit, Kenneth $u Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York
700    1_
$a Pearlman, Rachel $u Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
700    1_
$a Pharoah, Paul D P $u Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
700    1_
$a Platz, Elizabeth A $u Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
700    1_
$a Potter, John D $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Rennert, Gad $u Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
700    1_
$a Sakoda, Lori C $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Research, Kaiser Permanente Northern California, Oakland, California
700    1_
$a Schafmayer, Clemens $u Department of General Surgery, University Hospital Rostock, Rostock, Germany
700    1_
$a Schmit, Stephanie L $u Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
700    1_
$a Schoen, Robert E $u Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
700    1_
$a Schumacher, Fredrick R $u Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio
700    1_
$a Slattery, Martha L $u Department of Internal Medicine, University of Utah, Salt Lake City, Utah
700    1_
$a Su, Yu-Ru $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Tangen, Catherine M $u SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Ulrich, Cornelia M $u Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, Utah
700    1_
$a van Duijnhoven, Franzel J B $u Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, the Netherlands
700    1_
$a Van Guelpen, Bethany $u Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden
700    1_
$a Visvanathan, Kala $u Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
700    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vodickova, Ludmila $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Wang, Xiaoliang $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a White, Emily $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington
700    1_
$a Wolk, Alicja $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Woods, Michael O $u Memorial University of Newfoundland, Discipline of Genetics, St John's, Newfoundland and Labrador, Canada
700    1_
$a Casey, Graham $u Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia
700    1_
$a Hsu, Li $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
700    1_
$a Jenkins, Mark A $u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
700    1_
$a Gruber, Stephen B $u Department of Preventive Medicine and University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California
700    1_
$a Peters, Ulrike $u Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington
700    1_
$a Zheng, Wei $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee
773    0_
$w MED00001877 $t Gastroenterology $x 1528-0012 $g Roč. 160, č. 4 (2021), s. 1164-1178.e6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33058866 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133303 $b ABA008
999    __
$a ok $b bmc $g 1714891 $s 1146521
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 160 $c 4 $d 1164-1178.e6 $e 20201012 $i 1528-0012 $m Gastroenterology $n Gastroenterology $x MED00001877
GRA    __
$a R01 CA067941 $p NCI NIH HHS $2 United States
GRA    __
$a U01 HG004446 $p NHGRI NIH HHS $2 United States
GRA    __
$a K05 CA154337 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201100003I $p NHLBI NIH HHS $2 United States
GRA    __
$a U01 CA067941 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA059045 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201100001I $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 CA197350 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA076366 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA188214 $p NCI NIH HHS $2 United States
GRA    __
$a R35 CA197735 $p NCI NIH HHS $2 United States
GRA    __
$a C8221/A19170 $p Cancer Research UK $2 United Kingdom
GRA    __
$a R01 CA204279 $p NCI NIH HHS $2 United States
GRA    __
$a U01 HG004438 $p NHGRI NIH HHS $2 United States
GRA    __
$a R37 CA227130 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA074799 $p NCI NIH HHS $2 United States
GRA    __
$a U10 CA037429 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA182883 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA072520 $p NCI NIH HHS $2 United States
GRA    __
$a P01 CA087969 $p NCI NIH HHS $2 United States
GRA    __
$a 14136 $p Cancer Research UK $2 United Kingdom
GRA    __
$a HHSN261201000035C $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA015704 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201100004I $p NHLBI NIH HHS $2 United States
GRA    __
$a P30 CA006973 $p NCI NIH HHS $2 United States
GRA    __
$a U24 CA074783 $p NCI NIH HHS $2 United States
GRA    __
$a P01 CA055075 $p NCI NIH HHS $2 United States
GRA    __
$a N01 CN067009 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA160356 $p NCI NIH HHS $2 United States
GRA    __
$a UG1 CA189974 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA151993 $p NCI NIH HHS $2 United States
GRA    __
$a P30 DK058404 $p NIDDK NIH HHS $2 United States
GRA    __
$a HHSN268201100046C $p NHLBI NIH HHS $2 United States
GRA    __
$a P30 DK034987 $p NIDDK NIH HHS $2 United States
GRA    __
$p Department of Health $2 United Kingdom
GRA    __
$a P50 CA150964 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA048998 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA137088 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA189184 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA167552 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201100003C $p WHI NIH HHS $2 United States
GRA    __
$a Z01 CP010200 $p Intramural NIH HHS $2 United States
GRA    __
$a U24 CA074794 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA164930 $p NCI NIH HHS $2 United States
GRA    __
$a N01PC35137 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA066635 $p NCI NIH HHS $2 United States
GRA    __
$a U24 CA074806 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA206110 $p NCI NIH HHS $2 United States
GRA    __
$a 1000143 $p Medical Research Council $2 United Kingdom
GRA    __
$a C490/A16561 $p Cancer Research UK $2 United Kingdom
GRA    __
$a R21 CA191312 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201200008C $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 CA137178 $p NCI NIH HHS $2 United States
GRA    __
$a U24 CA097735 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA074794 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA008748 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA167551 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN261201300011C $p CCR NIH HHS $2 United States
GRA    __
$a HHSN261201300012I $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA014089 $p NCI NIH HHS $2 United States
GRA    __
$a C570/A16491 $p Cancer Research UK $2 United Kingdom
GRA    __
$a R01 CA081488 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA143237 $p NCI NIH HHS $2 United States
GRA    __
$a N01PC35142 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN271201100004C $p NIA NIH HHS $2 United States
GRA    __
$a R01 CA201407 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA063464 $p NCI NIH HHS $2 United States
GRA    __
$a P01 CA033619 $p NCI NIH HHS $2 United States
GRA    __
$a UM1 CA186107 $p NCI NIH HHS $2 United States
GRA    __
$a MR/M012190/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a HHSN268201100002C $p WHI NIH HHS $2 United States
GRA    __
$a R01 CA207371 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN261201300021C $p NCI NIH HHS $2 United States
GRA    __
$a R03 CA153323 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN261201000035I $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA144040 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA042182 $p NCI NIH HHS $2 United States
GRA    __
$a C588/A19167 $p Cancer Research UK $2 United Kingdom
GRA    __
$a R01 CA060987 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA097735 $p NCI NIH HHS $2 United States
GRA    __
$a T32 ES013678 $p NIEHS NIH HHS $2 United States
GRA    __
$a R01 CA136726 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA016058 $p NCI NIH HHS $2 United States
GRA    __
$a UM1 CA167552 $p NCI NIH HHS $2 United States
GRA    __
$a K05 CA152715 $p NCI NIH HHS $2 United States
GRA    __
$a P20 CA252728 $p NCI NIH HHS $2 United States
GRA    __
$a UM1 CA167551 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA122839 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN261201500005C $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201100002I $p NHLBI NIH HHS $2 United States
GRA    __
$a U01 CA074783 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA084968 $p NCI NIH HHS $2 United States
GRA    __
$a KL2 TR000421 $p NCATS NIH HHS $2 United States
GRA    __
$a U24 CA074799 $p NCI NIH HHS $2 United States
GRA    __
$a P01 CA196569 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA074806 $p NCI NIH HHS $2 United States
GRA    __
$a U24 CA074800 $p NCI NIH HHS $2 United States
GRA    __
$a P50 CA127003 $p NCI NIH HHS $2 United States
GRA    __
$a UM1 CA182883 $p NCI NIH HHS $2 United States
GRA    __
$a K07 CA190673 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201200008I $p NHLBI NIH HHS $2 United States
GRA    __
$a HHSN261201000121C $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA193677 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA164973 $p NCI NIH HHS $2 United States
GRA    __
$a R37 CA054281 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA074800 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201100001C $p WHI NIH HHS $2 United States
GRA    __
$a HHSN268201100004C $p WHI NIH HHS $2 United States
GRA    __
$a R01 CA097325 $p NCI NIH HHS $2 United States
GRA    __
$a U19 CA148107 $p NCI NIH HHS $2 United States
GRA    __
$a N01 CN043302 $p NCI NIH HHS $2 United States
GRA    __
$a NV17-30920A $p MZ0
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace